Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where the dibromomethyl group enables further functionalization. Its ester moiety facilitates coupling reactions in organic synthesis, making it valuable in constructing complex molecules for medicinal chemistry. Also employed in agrochemical research for designing novel pesticides with enhanced bioavailability and stability due to the fluorine substitution. The compound's reactivity allows for selective transformations, supporting its role in building blocks for heterocyclic compounds.